Table 4.
Association of type and level of health-care facility implementing GeneXpert Mycobacterium tuberculosis/rifampicin machines and successful test outcome
| Category | Utilization (n=366), n (%) | Successful test, n (%) | F (df1,2) | P | Mean±SD | Pa |
|---|---|---|---|---|---|---|
| Total | 354,321 | 324,248 | ||||
| Facility type | ||||||
| Public | 304,844 (86.0) | 279,100 (91.5) | 21.81 (1, 324246) | 0.02 | 1.08±0.27 | |
| Private | 49,477 (14.0) | 45,148 (91.3) | 1.09±0.28 | |||
| Facility level | ||||||
| Primary | 26,584 (7.5) | 23,740 (89.3) | 41.24 (2,324245) | <0.01 | 1.84±0.36 | <0.01 |
| Secondary | 265,183 (74.8) | 242,809 (91.6) | 1.83±0.37 | |||
| Tertiary | 62,554 (17.7) | 57,699 (92.2) | 1.84±0.36 | 0.83 |
F – Measure of difference in variance between and within groups; SD – Standard deviation; aP – Post hoc test; P<0.05